These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18105752)

  • 21. [Effects of 2-benzyl-2-imidazoline (priscol) on the pressure of the normal pulmonary circulation; experimental research].
    PANUCCIO P; CORTI L; CAINI B; GALLINI R; PRINCIPE U
    Sperimentale; 1955 Dec; 105(7-12):117-25. PubMed ID: 13337495
    [No Abstract]   [Full Text] [Related]  

  • 22. Persistent pulmonary hypertension in a newborn with congenital diaphragmeatic hernia: successful management with tolazoline.
    Levy RJ; Rosenthal A; Freed MD; Smith CD; Eraklis A; Nadas AS
    Pediatrics; 1977 Nov; 60(5):740-2. PubMed ID: 917638
    [No Abstract]   [Full Text] [Related]  

  • 23. [Disinversion by sparteine of the vascular effects of adrenaline inverted by tolazoline (priscol)].
    HAZARD R; CORTEGGIANI E; RENIERCORNEC A
    C R Seances Soc Biol Fil; 1955 Mar; 149(5-6):465-7. PubMed ID: 13261377
    [No Abstract]   [Full Text] [Related]  

  • 24. Toxicological and pharmacological data concerning 2-benzyl-imidazoline hydrochloride (priscol).
    BARRETT W; CAMERON A
    Fed Proc; 1948 Mar; 7(1 Pt 1):205. PubMed ID: 18857923
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacology of tolazoline.
    Ward RM
    Clin Perinatol; 1984 Oct; 11(3):703-13. PubMed ID: 6386273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor interactrions of imidazolines. VI. Significance of carbon bridge separating phenyl and imidazoline rings of tolazoline-like alpha adrenergic imidazolines.
    Ruffolo RR; Yaden EL; Waddell JE; Dillard RD
    J Pharmacol Exp Ther; 1980 Sep; 214(3):535-40. PubMed ID: 6105202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tolazoline-HCl in cardio-respiratory adaptation of newborns with respiratory distress syndrome (author's transl)].
    Tulassay T; Kiszel J; Csömör S; Machay T; Mártha I
    Monatsschr Kinderheilkd; 1981 Oct; 129(10):571-4. PubMed ID: 7335091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of imidazoline and nonimidazoline alpha-adrenergic agents, including xylazine, medetomidine, yohimbine, tolazoline, and atipamezole, on aggregation of bovine and equine platelets.
    Yokota S; Hikasa Y; Shimura I; Kusunose S
    Am J Vet Res; 2013 Mar; 74(3):395-402. PubMed ID: 23438114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of priscoline on peripheral blood flow in normal subjects and patients with peripheral vascular disorders.
    VAN ITALLIE TB; CLARKE CW
    Circulation; 1951 Jun; 3(6):820-9. PubMed ID: 14848931
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of vasodilator drugs on skin blood-flow in peripheral vascular occlusion. A double-blind trial using tolazoline.
    Thomas M; Campbell H; Heard G
    Br J Surg; 1968 Aug; 55(8):588-90. PubMed ID: 4874477
    [No Abstract]   [Full Text] [Related]  

  • 31. Priscol in circulatory deficiency.
    GARDNER LD
    J Ment Sci; 1951 Apr; 97(407):278-89. PubMed ID: 14824879
    [No Abstract]   [Full Text] [Related]  

  • 32. Peripheral vascular disease.
    LILLY GD
    J Fla Med Assoc (1914); 1946 Sep; 33():141-4. PubMed ID: 20995225
    [No Abstract]   [Full Text] [Related]  

  • 33. Detoxification of 2-benzyl-imidazoline hydrochloride (priscol) by incubation with hepatic slices from the rat.
    RICHARDS B; CAMERON A
    Fed Proc; 1948 Mar; 7(1 Pt 1):251. PubMed ID: 18861293
    [No Abstract]   [Full Text] [Related]  

  • 34. Recent advances in peripheral vascular disease.
    DOANE JC
    Trans Stud Coll Physicians Phila; 1946 Apr; 14():33. PubMed ID: 20993977
    [No Abstract]   [Full Text] [Related]  

  • 35. Recent trends in the diagnosis and treatment of peripheral vascular disease.
    KRAMER DW
    Clinics; 1946 Jun; 5(1):276-97. PubMed ID: 20997161
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of 2-imidazolines as anti-sickling agents.
    Chang H; Ewert SM; Nagel RL
    Mol Pharmacol; 1983 May; 23(3):731-4. PubMed ID: 6865916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Benzyl-imidazoline in the treatment of angiospasm in eclampsia].
    BOZZO GB
    Quad Clin Ostet Ginecol; 1952 Aug; 7(8):593-600. PubMed ID: 13004234
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative effects of ether, alcohol, tetraethylammonium, and priscoline in producing vasodilatation in peripheral vascular conditions.
    REEDY WJ
    J Lab Clin Med; 1951 Mar; 37(3):365-73. PubMed ID: 14824659
    [No Abstract]   [Full Text] [Related]  

  • 39. A pharmacodynamic and pharmacokinetic study of tolazoline in the neonate.
    Monin P; Vert P; Morselli PL
    Dev Pharmacol Ther; 1982; 4 Suppl():124-8. PubMed ID: 7128383
    [No Abstract]   [Full Text] [Related]  

  • 40. Priscol in the prevention and management of leprotic lagophthalmos.
    Nema HV; Mathur JS
    Lepr Rev; 1967 Jul; 38(3):159-61. PubMed ID: 6045747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.